KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in CashDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Elanco Animal Health (ELAN) Asset Writedowns and Impairment (2017 - 2025)

Historic Asset Writedowns and Impairment for Elanco Animal Health (ELAN) over the last 9 years, with Q3 2025 value amounting to $24.0 million.

  • Elanco Animal Health's Asset Writedowns and Impairment rose 6000.0% to $24.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $71.0 million, marking a year-over-year increase of 5106.38%. This contributed to the annual value of $81.0 million for FY2024, which is 15312.5% up from last year.
  • According to the latest figures from Q3 2025, Elanco Animal Health's Asset Writedowns and Impairment is $24.0 million, which was up 6000.0% from $5.0 million recorded in Q4 2024.
  • Over the past 5 years, Elanco Animal Health's Asset Writedowns and Impairment peaked at $269.0 million during Q2 2021, and registered a low of $5.0 million during Q3 2023.
  • For the 5-year period, Elanco Animal Health's Asset Writedowns and Impairment averaged around $45.6 million, with its median value being $22.0 million (2022).
  • In the last 5 years, Elanco Animal Health's Asset Writedowns and Impairment skyrocketed by 886666.67% in 2021 and then crashed by 8148.15% in 2024.
  • Elanco Animal Health's Asset Writedowns and Impairment (Quarter) stood at $11.0 million in 2021, then soared by 436.36% to $59.0 million in 2022, then tumbled by 54.24% to $27.0 million in 2023, then plummeted by 81.48% to $5.0 million in 2024, then skyrocketed by 380.0% to $24.0 million in 2025.
  • Its last three reported values are $24.0 million in Q3 2025, $5.0 million for Q4 2024, and $15.0 million during Q3 2024.